Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.116  + (§ 46.116)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.117  + (§ 46.117)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.123  + (§ 46.123)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.124  + (§ 46.124)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 47-001  + (§ 47)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 47-002  + (§ 47)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 48  + (§ 48)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 49  + (§ 49)
• Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 5  + (§ 5)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 50  + (§ 50)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.20  + (§ 50.20)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.22  + (§ 50.22)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.23  + (§ 50.23)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.24  + (§ 50.24)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.25 (a) - (b)  + (§ 50.25 (a) - (b))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.25 (e)  + (§ 50.25 (e))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.27  + (§ 50.27)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3  + (§ 50.3)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (c)  + (§ 50.3 (c))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (d)  + (§ 50.3 (d))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (e)  + (§ 50.3 (e))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (f)  + (§ 50.3 (f))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (g)  + (§ 50.3 (g))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (h)  + (§ 50.3 (h))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (i)  + (§ 50.3 (i))

• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (j)  + (§ 50.3 (j))

• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (k)-001  + (§ 50.3 (k))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (k)-002  + (§ 50.3 (k))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (l)  + (§ 50.3 (l))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (m)  + (§ 50.3 (m))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (n)  + (§ 50.3 (n))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (o)  + (§ 50.3 (o))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (p)  + (§ 50.3 (p))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (q)  + (§ 50.3 (q))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (r)  + (§ 50.3 (r))
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (s)  + (§ 50.3 (s))
• Reference:AUT Ärztegesetz 08-Mar-2023 § 51 (3)  + (§ 51 (3))
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 53  + (§ 53)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 54  + (§ 54)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.1-001  + (§ 54.1)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.1-002  + (§ 54.1)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 disclosure  + (§ 54.4 disclosure)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 list of investigators  + (§ 54.4 list of investigators)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.6  + (§ 54.6)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 55  + (§ 55)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.102 (m)  + (§ 56.102 (m))
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.103  + (§ 56.103)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.104  + (§ 56.104)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.104 (d)  + (§ 56.104 (d))
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.105  + (§ 56.105)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.109  + (§ 56.109)